Gastrointestinal Stromal Tumor (GIST)

DBCOND0037254Digestive System DiseasesMusculoskeletal and Connective Tissue Diseases

Gastrointestinal Stromal Tumor (GIST) is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Gastrointestinal Stromal Tumors · Gastrointestinal Stromal Tumor · GIST · Gastro-intestinal Stromal Tumors (GIST) · Gastrointestinal Stroma Tumors
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0452911ICD-10C49.ASNOMED CT1187383001MedDRA10051066UMLSC0238198

What you can answer from here — as of September 26, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
281Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Gastrointestinal Stromal Tumor (GIST) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In